Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PROTAGONIST THERAPEUTICS, INC.
11:01aProtagonist Therapeutics Gets $7.5 Million Milestone Payment from Johnson & Johnson's J..
MT
07:01aProtagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
PR
10/13PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/12PROTAGONIST THERAPEUTICS : Shares Drop on Elevated Volume
MT
10/12PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/12PROTAGONIST THERAPEUTICS : SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $..
MT
10/12PROTAGONIST THERAPEUTICS : JPMorgan Upgrades Protagonist Therapeutics to Overweight From N..
MT
10/12PROTAGONIST THERAPEUTICS : to Present at the Jefferies Next Generation IBD Therapeutics Su..
PR
10/11PROTAGONIST THERAPEUTICS : Northland Capital Markets Upgrades Protagonist Therapeutics to ..
MT
10/11Health Care Stocks Trade Lower Premarket Monday
MT
10/11PROTAGONIST THERAPEUTICS : Health Care
MT
10/11PROTAGONIST THERAPEUTICS : Says FDA Lifts Clinical Hold on Rusfertide Trials; Shares Surge..
MT
10/11PROTAGONIST THERAPEUTICS : Announces Removal of FDA Clinical Hold on the Rusfertide Clinic..
PR
10/11Protagonist Therapeutics Announces Removal of Fda Clinical Hold on the Rusfertide Clini..
CI
10/11Protagonist Therapeutics' Clinical Hold on Rusfertide Lifted
DJ
More most relevant news
All news about PROTAGONIST THERAPEUTICS, INC.
11:01aProtagonist Therapeutics Gets $7.5 Million Milestone Payment from Johnson & Johnson's J..
MT
07:01aProtagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
PR
10/13PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/13NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
10/12PROTAGONIST THERAPEUTICS : Shares Drop on Elevated Volume
MT
10/12PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/12WALL STREET STOCK EXCHANGE : It's just a period of market normalization
10/12PROTAGONIST THERAPEUTICS : SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $..
MT
10/12PROTAGONIST THERAPEUTICS : JPMorgan Upgrades Protagonist Therapeutics to Overweight From N..
MT
10/12PROTAGONIST THERAPEUTICS : to Present at the Jefferies Next Generation IBD Therapeutics Su..
PR
More news
News in other languages on PROTAGONIST THERAPEUTICS, INC.
11:01aProtagonist Therapeutics obtient un paiement d'étape de 7,5 millions de dollars de la p..
10/12Les actions de Protagonist Therapeutics chutent en raison d'un volume élevé
10/11Les actions du secteur de la santé en baisse lundi en fin de journée
10/11Les actions du secteur de la santé à la dérive lundi alors que les biotechnologies grim..
09/20Les études cliniques de Protagonist Therapeutics sur le Rusfertide sont suspendues par ..
More news
Analyst Recommendations on PROTAGONIST THERAPEUTICS, INC.
10/13PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/12PROTAGONIST THERAPEUTICS : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
10/12PROTAGONIST THERAPEUTICS : SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $..
MT
10/12PROTAGONIST THERAPEUTICS : JPMorgan Upgrades Protagonist Therapeutics to Overweight From N..
MT
10/12ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex...
More recommendations
Press releases
07:01aProtagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
PR
10/12PROTAGONIST THERAPEUTICS : to Present at the Jefferies Next Generation IBD Therapeutics Su..
PR
10/11PROTAGONIST THERAPEUTICS : Announces Removal of FDA Clinical Hold on the Rusfertide Clinic..
PR
10/05PROTAGONIST THERAPEUTICS : Announces Data from Phase 2 Rusfertide Study in Hereditary Hemo..
AQ
09/22PROTAGONIST ALERT : Bragar Eagel & Squire, P.C. is Investigating Protagonist on Behalf of ..
BU
More press releases
Upcoming event on PROTAGONIST THERAPEUTICS, INC.